The TMPRSS2:ERG gene fusion (T:E fusion) puts ERG under the androgen receptor–regulated (AR-regulated) expression of TMPRSS2, and it is an early truncal alteration found in about half of prostate adenocarcinoma (PCa) cases in men of European ancestry. Here, AR is linked to prostate adenocarcinoma.